Andon Health Co., Ltd.

Andon Health Co. has seen a notable rise in its stock price, achieving a significant increase over the past week and a remarkable five-year growth. Despite recent challenges in net profit, the company maintains a strong market position with a competitive dividend yield and substantial market capitalization.

Andon Health Co., Ltd. faced a significant decline in stock value on June 17, 2026, reaching an intraday low. Despite this short-term volatility, the company has demonstrated strong long-term performance, with an 84.61% increase over the past year and a notable 769.05% rise over five years.

Andon Health Co. has shown strong market performance, gaining 5.84% on June 16, 2026, despite a slight decline in the China Shanghai Composite. The company has achieved impressive returns over the past year and year-to-date, while maintaining a high dividend yield and a favorable market valuation.

Andon Health Co., Ltd. has seen a notable increase in its stock price, reaching an intraday high while outperforming the broader market. Despite a recent decline, the company has shown substantial long-term growth. Key financial metrics indicate a favorable valuation, though it faces challenges with negative net profit growth.

Andon Health Co., Ltd. saw its stock price decline significantly, reflecting broader market trends. The company reported a notable drop in net sales and profit, continuing a streak of negative results over 13 quarters. Despite a year-to-date increase, recent performance has raised concerns about its financial stability.

Andon Health Co. faced a significant stock decline today, marking a 4.02% drop. Over the past week and month, the stock has decreased by 15.83% and 14.65%, respectively, outpacing the broader market. The company has reported ongoing financial challenges, including declining net sales and profits.

Andon Health Co. faced a significant stock decline, dropping 3.83% on June 8, 2026, amid a challenging market. The company reported a notable decrease in net sales and profit, raising concerns about its financial leverage. Despite strong year-to-date and five-year performance, recent metrics indicate underlying difficulties.

Andon Health Co. faced a notable decline in stock performance, dropping significantly today and over the past week. Despite strong year-to-date gains, recent financial metrics reveal a sharp decrease in net profit and sales, alongside a concerning debt-equity ratio, raising questions about its market position.

Andon Health Co., Ltd. faced a notable stock decline today, contrasting with a slight gain in the China Shanghai Composite. The company reported a significant drop in net sales and profit, continuing a negative trend over 13 quarters. Despite past long-term growth, current challenges reflect sector volatility.

Andon Health Co. has seen a notable rise in its stock price, achieving significant gains over various time frames. Despite impressive year-to-date performance, the company faces challenges, including declining net sales and profits, alongside a high debt-equity ratio, indicating potential financial strain amid its market success.

Andon Health Co., Ltd. has seen a notable increase in its stock price, reaching an intraday high amid mixed market conditions. Over the past year, the company has significantly outperformed the broader market, despite facing ongoing financial challenges, including declining net sales and profits.

Andon Health Co., Ltd. has shown remarkable stock performance, gaining 10.0% today and achieving an intraday high. Over the past week, the company has increased by over 10%, with a notable one-month gain of 54.63%. Despite challenges in operating profit, its year-to-date surge stands at 71.43%.

Andon Health Co., Ltd. saw a notable increase in its stock price on March 20, 2026, amid a declining broader market. The company has experienced significant gains over the past week and month, despite facing challenges in financial performance, including reduced operating profit and net sales.

Andon Health Co., Ltd. has seen a notable increase in its stock price, outperforming the China Shanghai Composite. The company has experienced significant gains over various time frames, despite facing challenges such as declining operating profit and negative results in recent quarters. Its market capitalization stands at CNY 18,799 million.

Andon Health Co., Ltd. saw a notable stock price decline today, contrasting with a minor drop in the broader market. Despite recent gains, the company faces significant financial challenges, including a sharp decrease in operating profit and net sales, alongside nine consecutive quarters of negative results. Its market capitalization remains substantial.

Andon Health Co., Ltd. saw a notable increase in its stock price on March 11, 2026, reaching an intraday high. The company's recent performance metrics indicate significant gains over various timeframes, despite facing challenges in financial results, including declines in operating profit and net profit growth.

Andon Health Co., Ltd. has seen a significant rise in its stock price, outperforming the broader market. Despite recent gains, the company faces challenges with declining operating profits and a substantial drop in net profit. With a market capitalization of CNY 18,799 million, it remains a key player in the Pharmaceuticals & Biotechnology sector.

Andon Health Co., Ltd. has experienced notable intraday gains, contrasting with a decline in the broader market. Despite a recent surge in stock performance, the company has struggled financially, reporting negative results for nine consecutive quarters, including a significant drop in net sales and profit.

Andon Health Co., Ltd. has seen a significant increase in its stock price today, contrasting with a decline in the broader market. Despite recent gains, the company faces challenges with declining net sales and profits, while showing notable long-term growth over five years. Its market capitalization stands at CNY 18,799 million.